446 related articles for article (PubMed ID: 23792768)
21. Immunocytochemical localization of estrogen receptors in spontaneous and experimentally induced canine benign prostatic hyperplasia.
Schulze H; Barrack ER
Prostate; 1987; 11(2):145-62. PubMed ID: 2444954
[TBL] [Abstract][Full Text] [Related]
22. Stromal androgen receptor roles in the development of normal prostate, benign prostate hyperplasia, and prostate cancer.
Wen S; Chang HC; Tian J; Shang Z; Niu Y; Chang C
Am J Pathol; 2015 Feb; 185(2):293-301. PubMed ID: 25432062
[TBL] [Abstract][Full Text] [Related]
23. Combination of Ligustri Lucidi Fructus with Ecliptae Herba and their phytoestrogen or phytoandrogen like active pharmaceutical ingredients alleviate oestrogen/testosterone-induced benign prostatic hyperplasia through regulating steroid 5-α-reductase.
Tao R; Liu E; Zhao X; Han L; Yu B; Mao H; Yang W; Gao X
Phytomedicine; 2022 Jul; 102():154169. PubMed ID: 35636178
[TBL] [Abstract][Full Text] [Related]
24. Elevated epithelial expression of interleukin-8 correlates with myofibroblast reactive stroma in benign prostatic hyperplasia.
Schauer IG; Ressler SJ; Tuxhorn JA; Dang TD; Rowley DR
Urology; 2008 Jul; 72(1):205-13. PubMed ID: 18314176
[TBL] [Abstract][Full Text] [Related]
25. Epithelial-to-mesenchymal transition and estrogen receptor α mediated epithelial dedifferentiation mark the development of benign prostatic hyperplasia.
Shao R; Shi J; Liu H; Shi X; Du X; Klocker H; Lee C; Zhu Y; Zhang J
Prostate; 2014 Jun; 74(9):970-82. PubMed ID: 24752964
[TBL] [Abstract][Full Text] [Related]
26. [Expressions of SIgA and alpha 1-AR in benign prostatic hyperplasia combined with chronic prostatitis and their implications].
Gao WJ; Wang YM; Wang CH; Yang XK; Wan L; Li WP
Zhonghua Nan Ke Xue; 2013 Apr; 19(4):315-20. PubMed ID: 23678709
[TBL] [Abstract][Full Text] [Related]
27. Transforming growth factor beta 1 and androgen receptors in prostate neoplasia.
Cardillo MR; Petrangeli E; Salvatori L; Ravenna L; Di Silverio F
Anal Quant Cytol Histol; 2000 Oct; 22(5):403-10. PubMed ID: 11064817
[TBL] [Abstract][Full Text] [Related]
28. Transcript profiling of the androgen signal in normal prostate, benign prostatic hyperplasia, and prostate cancer.
Bauman DR; Steckelbroeck S; Peehl DM; Penning TM
Endocrinology; 2006 Dec; 147(12):5806-16. PubMed ID: 16959841
[TBL] [Abstract][Full Text] [Related]
29. [Androgen receptor and 5 alpha-reductase activity in the epithelium and the stroma of human benign prostatic hyperplasia].
Oishi K; Okada K; Yoshida O; Romijn JC; Bolt de Vries J; Schröder FH
Hinyokika Kiyo; 1985 May; 31(5):785-90. PubMed ID: 2413745
[TBL] [Abstract][Full Text] [Related]
30. Chrysophanic acid reduces testosterone-induced benign prostatic hyperplasia in rats by suppressing 5α-reductase and extracellular signal-regulated kinase.
Youn DH; Park J; Kim HL; Jung Y; Kang J; Jeong MY; Sethi G; Seok Ahn K; Um JY
Oncotarget; 2017 Feb; 8(6):9500-9512. PubMed ID: 27880726
[TBL] [Abstract][Full Text] [Related]
31. Expression of androgen and estrogen related proteins in normal weight and obese prostate cancer patients.
Gross M; Ramirez C; Luthringer D; Nepomuceno E; Vollmer R; Burchette J; Freedland SJ
Prostate; 2009 Apr; 69(5):520-7. PubMed ID: 19107851
[TBL] [Abstract][Full Text] [Related]
32. [Expressions of the androgen receptor in normal prostate, benign prostatic hyperplasia and prostate cancer].
Zeng R; Liu ZY; Sun YH; Xu CL; Gao X; Jiao L
Zhonghua Nan Ke Xue; 2010 Nov; 16(11):967-72. PubMed ID: 21218636
[TBL] [Abstract][Full Text] [Related]
33. Prostatic osteopontin expression is associated with symptomatic benign prostatic hyperplasia.
Popovics P; Awadallah WN; Kohrt SE; Case TC; Miller NL; Ricke EA; Huang W; Ramirez-Solano M; Liu Q; Vezina CM; Matusik RJ; Ricke WA; Grabowska MM
Prostate; 2020 Jul; 80(10):731-741. PubMed ID: 32356572
[TBL] [Abstract][Full Text] [Related]
34. Age-dependent expression of the androgen receptor gene in the prostate and its implication in glandular differentiation and hyperplasia.
Prins GS; Jung MH; Vellanoweth RL; Chatterjee B; Roy AK
Dev Genet; 1996; 18(2):99-106. PubMed ID: 8934871
[TBL] [Abstract][Full Text] [Related]
35. Androgen receptor roles in the development of benign prostate hyperplasia.
Izumi K; Mizokami A; Lin WJ; Lai KP; Chang C
Am J Pathol; 2013 Jun; 182(6):1942-9. PubMed ID: 23570837
[TBL] [Abstract][Full Text] [Related]
36. Increased androgen receptor expression correlates with development of age-dependent, lobe-specific spontaneous hyperplasia of the brown Norway rat prostate.
Banerjee PP; Banerjee S; Brown TR
Endocrinology; 2001 Sep; 142(9):4066-75. PubMed ID: 11517186
[TBL] [Abstract][Full Text] [Related]
37. Immunolocalization of androgen receptors, estrogen alpha receptors, and estrogen beta receptors in experimentally induced canine prostatic hyperplasia.
Gallardo F; Lloreta J; García F; Moll X; Baró T; González LA; Morote J; Reventos J; Mogas T
J Androl; 2009; 30(3):240-7. PubMed ID: 19136389
[TBL] [Abstract][Full Text] [Related]
38. Atrophic effects of antiandrogen, chlormadinone acetate (CMA) on dog prostate with spontaneous benign prostatic hyperplasia.
Murakoshi M; Tagawa M; Ikeda R
J Toxicol Sci; 2000 Aug; 25(3):143-50. PubMed ID: 10987120
[TBL] [Abstract][Full Text] [Related]
39. A role for epithelial-mesenchymal transition in the etiology of benign prostatic hyperplasia.
Alonso-Magdalena P; Brössner C; Reiner A; Cheng G; Sugiyama N; Warner M; Gustafsson JA
Proc Natl Acad Sci U S A; 2009 Feb; 106(8):2859-63. PubMed ID: 19196965
[TBL] [Abstract][Full Text] [Related]
40. Transforming growth factor beta 1 and its receptor types I and II. Comparison in human normal prostate, benign prostatic hyperplasia, and prostatic carcinoma.
Royuela M; De Miguel MP; Bethencourt FR; Sanchez-Chapado M; Fraile B; Paniagua R
Growth Factors; 1998; 16(2):101-10. PubMed ID: 9932228
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
